The Valley Desk

NCT00702052 · Interventional trial

Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy

Overall registry status Completed

Phase 2

Conditions Lymphoma, Mantle- Cell

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov